Listed

Standard Biotools Inc.: Form 10-Q for the period ended Mar 31, 2017

Filed with the SEC on May 9, 2017 and accepted by EDGAR at May 9, 2017, 16:14 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2017-01-01 to 2017-03-31$10.9mus-gaap:CostOfGoodsSold
Research and development3 months2017-01-01 to 2017-03-31$8.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2017-01-01 to 2017-03-31$22.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2017-01-01 to 2017-03-31−$17.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2017-01-01 to 2017-03-31$1.5mus-gaap:InterestExpense
Income tax3 months2017-01-01 to 2017-03-31−$1.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2017-01-01 to 2017-03-31−$17.2mus-gaap:NetIncomeLoss
Diluted EPS3 months2017-01-01 to 2017-03-31−$0.59us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow3 months2017-01-01 to 2017-03-31−$8.5mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2017-01-01 to 2017-03-31$692.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2017-03-31$44.1mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2017-03-31$86.1mus-gaap:AssetsCurrent
Total assetsAt period end2017-03-31$292.5mus-gaap:Assets
Current liabilitiesAt period end2017-03-31$31.3mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2017-03-31$254.0mus-gaap:Liabilities
Shareholders' equityAt period end2017-03-31$38.5mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001162194-17-000042. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.